CN1128624C - Process for preparing powdered medicine to treat rhinitis and nasosinusitis - Google Patents

Process for preparing powdered medicine to treat rhinitis and nasosinusitis Download PDF

Info

Publication number
CN1128624C
CN1128624C CN00105093A CN00105093A CN1128624C CN 1128624 C CN1128624 C CN 1128624C CN 00105093 A CN00105093 A CN 00105093A CN 00105093 A CN00105093 A CN 00105093A CN 1128624 C CN1128624 C CN 1128624C
Authority
CN
China
Prior art keywords
medicine
herba
radix
chinese herbal
nasosinusitis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN00105093A
Other languages
Chinese (zh)
Other versions
CN1320433A (en
Inventor
张占军
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN00105093A priority Critical patent/CN1128624C/en
Publication of CN1320433A publication Critical patent/CN1320433A/en
Application granted granted Critical
Publication of CN1128624C publication Critical patent/CN1128624C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to powdered medicine for treating rhinitis and nasosinusitis, which is formed by respectively crushing, sieving and mixing a plurality of kinds of finishedwestern medicine and a plurality of kinds of Chinese herbal medicine according to a certain compounding ratio. So long as a patient uses warm water to soak the medicine for several minutes, the medicine is internally taken in one or two treating courses. The purulent secretion and the clinical symptoms of a patient with rhinitis and nasosinusitis disappear without operations. The nose ventilation is normal, and the X ray nasosinusitis returns to normal without recurrence. By more than 600 persons'clinical curative results, the cure rate is 84.7%, the effective rate is 12.1%, and thus, patients' diseases are cured without pain and risk.

Description

A kind of manufacture method for the treatment of rhinitis, sinusitis powder
The present invention relates to treat the manufacture method of rhinitis, sinusitis medicine.
The Pharmaceuticals of treatment rhinitis, sinusitis is many at present, but mainly is that Chinese medicine and western medicine is independent separately the making or surgical operation.Its composition of Chinese medicine for the treatment of this disease is a Chinese herbal medicine, does not contain the antibiotic of killing bacteria, only plays the effect of bacteria growing inhibiting, and it does not contain the antiallergic composition yet, and some medicine does not contain the composition of blood circulation promoting and blood stasis dispelling yet.The western medical treatment way mainly is to use the surgical intervention means, and as the puncture antral flushing, it is big, risky that radical maxillary sinusotomy etc. belong to its misery of traumatic treatment means, and the patient generally is reluctant to accept, and has defectives such as easy infection, easy recurrence.
The objective of the invention is to adopt the powder of Chinese medicine and western medicine phase mixing manufacture, make the patient for oral administration, need not operation, make the patient in no pain, devoid of risk, cure diseases such as rhinitis, sinusitis.
Above-mentioned purpose is achieved in that after it is sieved by some kinds of finished product Western medicine and some kinds of Chinese herbal medicine pulverize separately and mixes.The kind of used finished product Western medicine and sheet thereof are counted ratio: acetylspiramycin, ciprofloxacin and oryzanol respectively are 100, prednisone, Piao Ermin and metronidazole respectively are 25-75, APC is 50-100, the kind of the Chinese herbal medicine that adopts and their weight ratio are: Herba Taraxaci, Radix Astragali, Spica Prunellae, Herba Patriniae, Flos Magnoliae, Fructus Xanthii, the Rhizoma Atractylodis Macrocephalae, Myrrha, Cortex Moutan, Herba Houttuyniae, Spina Gleditsiae, Radix Gentianae, Fructus Gardeniae, Herba Artemisiae Scopariae, Radix Rubiae, Semen Trichosanthis, Exocarpium Benincasae, Bombyx Batryticatus, Pheretima, the Radix Angelicae Dahuricae, Rhizoma Chuanxiong, rhizoma sparganic and Rhizoma Curcumae respectively are 100, each 30-70 of Radix Glycyrrhizae and Radix Saposhnikoviae, Herba Asari is 20-40, and Scolopendra is 5-10.Above-mentioned finished product Western medicine and Chinese herbal medicine pulverize separately are sieved the back by 1: the mixing of 120-130 weight ratio gets final product.
Use that this powder treatment rhinitis, sinusitis can make purulent secretion and clinical symptom disappearance, BITONG gas is normal, X line nasal sinuses recovers normal, do not have recurrence.Through to routine clinical treatment result surplus 600, cure rate reaches 84.7%, effective percentage 12.1%, and total effective rate reaches 96.8%.The patient will brew that get final product one, two course of treatment for oral administration after several minutes with eliminating cold for resuscitation water, and the patient need not operation, no pain, devoid of risk.
Embodiment 1: 60 of acetylspiramycins (pharmaceutical factory of 0.1g/ sheet Zhumadian old name for the Arabian countries in the Middle East), ciprofloxacin 60 (0.1g/ sheet Henan work of nature pharmaceutical factory), 60 (10mg/ sheet Hebi pharmaceutical factory) prednisones of oryzanol 30 (5mg/ sheet White Cloud Mountain pharmacy head factory), Piao Er quick 30 (4mg/ sheet Jiaozhuo zero diopter drugmaker), metronidazole 30 (0.2g/ sheet Jiaozhuo zero diopter drugmaker), APC45 sheets (Zhengzhou chemical pharmaceutical factory), they are mixed, pulverize through micromill, cross 160 mesh sieves and be mixed into powder.Then with Chinese herbal medicine Herba Taraxaci, Radix Astragali, Spica Prunellae, Herba Patriniae, Flos Magnoliae, Fructus Xanthii, the Rhizoma Atractylodis Macrocephalae, Myrrha, Cortex Moutan, Herba Houttuyniae, Spina Gleditsiae, Radix Gentianae, Fructus Gardeniae, Herba Artemisiae Scopariae, Radix Rubiae, Semen Trichosanthis, Exocarpium Benincasae, Bombyx Batryticatus, Pheretima, spend in vain, each 100 gram of Rhizoma Chuanxiong, rhizoma sparganic, Rhizoma Curcumae, Radix Glycyrrhizae, each 50 gram of Radix Saposhnikoviae, Herba Asari 30 grams, Scolopendra 6 grams, mix after the pulverizer grinding and processing is crossed 160 mesh sieves, be mixed into Chinese herbal medicine powder, promptly became required powder by 1: 125 behind the uniform mixing by above-mentioned Western medicine powder and Chinese herbal medicine powder then.
Embodiment 2: each 60 of acetylspiramycin, ciprofloxacin and oryzanol, each 15 of prednisone, Piao Ermin and metronidazoles, APC are 30, all medicine content and manufacturing firms, used Chinese herbal medicine is identical with preceding 22 highly seasoned amounts in the example 1 respectively to be 100 grams, each 30 gram of Radix Glycyrrhizae and Radix Saposhnikoviae, Herba Asari 20 grams, Scolopendra is that 5 grams, manufacture method are identical with example 1.
Embodiment 3: each 60 on husky star and Gu Wei yarn, prednisone, Piao Ermin and metronidazole each 45, APC60 sheet in acetylspiramycin, the ring, institute's medication content is identical with embodiment 1 with manufacturing firm.Used Chinese herbal medicine is identical with preceding 22 flavor medicine weight in the example 1 respectively to be 100 grams, and Radix Glycyrrhizae and Radix Saposhnikoviae are equipped with 70 grams, and Herba Asari 40 grams, Scolopendra are 10 grams, and manufacture method is identical with example 1.

Claims (1)

1, a kind of treatment rhinitis, sinusitis powder, it mixes after being sieved by finished product Western medicine and Chinese herbal medicine pulverize separately, it is characterized in that: the kind of finished product Western medicine and sheet thereof are counted ratio and are: acetylspiramycin, ciprofloxacin and oryzanol each 100; Prednisone, Piao Ermin and first nitre respectively are 25-75, and APC is 50-100, and the kind of the Chinese herbal medicine of employing and their weight ratio are; Herba Taraxaci, Radix Astragali, Spica Prunellae, Herba Patriniae, Flos Magnoliae, Fructus Xanthii, the Rhizoma Atractylodis Macrocephalae, Myrrha, Cortex Moutan, Herba Houttuyniae, Spina Gleditsiae, Radix Gentianae, Fructus Gardeniae, Herba Artemisiae Scopariae, Radix Rubiae, Semen Trichosanthis, Exocarpium Benincasae, Bombyx Batryticatus, Pheretima, the Radix Angelicae Dahuricae, Rhizoma Chuanxiong, rhizoma sparganic and Rhizoma Curcumae respectively are 100, give birth to sweet
Grass and each 30-70 of Radix Saposhnikoviae, Herba Asari is 20-40, and Scolopendra is 5-10, and finished product Western medicine and Chinese herbal medicine are by 1: the 120-130 weight ratio is mixed.
CN00105093A 2000-04-25 2000-04-25 Process for preparing powdered medicine to treat rhinitis and nasosinusitis Expired - Fee Related CN1128624C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN00105093A CN1128624C (en) 2000-04-25 2000-04-25 Process for preparing powdered medicine to treat rhinitis and nasosinusitis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN00105093A CN1128624C (en) 2000-04-25 2000-04-25 Process for preparing powdered medicine to treat rhinitis and nasosinusitis

Publications (2)

Publication Number Publication Date
CN1320433A CN1320433A (en) 2001-11-07
CN1128624C true CN1128624C (en) 2003-11-26

Family

ID=4577523

Family Applications (1)

Application Number Title Priority Date Filing Date
CN00105093A Expired - Fee Related CN1128624C (en) 2000-04-25 2000-04-25 Process for preparing powdered medicine to treat rhinitis and nasosinusitis

Country Status (1)

Country Link
CN (1) CN1128624C (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1306946C (en) * 2004-09-21 2007-03-28 李庆才 Snuffle dredging capsule
CN100335097C (en) * 2005-08-04 2007-09-05 刘益斌 Medicament for treating rhinitis
CN100337655C (en) * 2005-09-28 2007-09-19 骆斌 Medicine preparation for preventing and treating allergic rhinitis and compliance rhinitis
CN100423757C (en) * 2005-12-30 2008-10-08 曹玉梅 Medicien for treating nasitis and nasosinusitis
CN100358560C (en) * 2006-11-20 2008-01-02 李淑洁 Orally administered Chinese medicinal mixture for treating infant allergic rhinitis and preparation process thereof
CN103611016B (en) * 2013-10-29 2016-03-23 于巧媛 A kind of Chinese medicine composition for the treatment of of allergic rhinitis
CN103705802B (en) * 2014-01-02 2015-09-30 王雪雁 A kind of pharmaceutical composition and application thereof for the treatment of otitis media
CN105012392A (en) * 2015-08-18 2015-11-04 付刚川 Traditional Chinese medicine composition for treating rhinitis and preparation method thereof
CN105326924A (en) * 2015-10-28 2016-02-17 周胜光 Allergy-removal rhinitis cream
CN106177107A (en) * 2016-06-30 2016-12-07 张学领 A kind of medicine treating rhinitis
CN107875228A (en) * 2017-11-30 2018-04-06 云南露源野生真菌研究所(有限合伙) A kind of Chinese medicine for treating rhinitis preparation and preparation method thereof

Also Published As

Publication number Publication date
CN1320433A (en) 2001-11-07

Similar Documents

Publication Publication Date Title
CN1061854C (en) Medicinal preparation for treatment and prevention of gynopathy
CN1128624C (en) Process for preparing powdered medicine to treat rhinitis and nasosinusitis
CN101322775B (en) Chinese medicine for treating psoriasis
CN100562336C (en) HUOXUEDAN and preparation method thereof
CN1060387C (en) Bone-knitting pill and producing process thereof
CN100333738C (en) Chinese medicinal ointment for treating bone diseases
CN1049586C (en) Dressing medicine for treating hyperosteogeny and the prepn. method
CN114767824A (en) Preparation for treating laryngeal cough and preparation method thereof
CN101036706A (en) Wine for promoting blood circulation by removing blood stasis and for eliminating rheumatism
CN103417788B (en) One treats fracture Chinese medicine for oral administration
CN102793845B (en) Traditional Chinese medicine composition for treating climacteric syndrome
CN104800799A (en) Traditional Chinese medicament for treating endometrial thickening with ovarian cysts
CN100371016C (en) Chinese traditional medicine preparation for curing mastopathy in installments
CN1322884C (en) Purple perilla capsule and process for preparing the same
CN104288421A (en) Traditional Chinese medicine composition for treating migraine
CN108904617A (en) The pharmaceutical composition and its preparation method and application for treating cranial vascular disease
CN103157011B (en) Traditional Chinese medicine composite for promoting fracture healing
CN1054052C (en) Comedo-elimination preparation
CN101297937B (en) Chinese patent medicine formulation for treating cervical vertebra disease and preparation thereof
CN1557365A (en) Medicine
CN1055845C (en) Dieda Huoxuesan powder for curing fracture and injury
CN104758346A (en) Medicine for treating migraine, as well as preparation method and preparation of medicine
CN1263493C (en) Medicine for treating chronic bronchitis and asthma
CN101108242B (en) Chinese patent drug treating women's barrenness and method of preparing the same
CN1062757C (en) Pregrant powder and preparing method therefor

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee